Brouky Score · 2026

Top VC Firms in Belgium

The 25 highest-scoring venture funds headquartered in Belgium, ranked from 50 eligible firms on a 110-point composite of portfolio outcomes, deal volume, risk adjustment and cheque-size fit.

61
Median score / 110
across eligible firms
50
Eligible firms
5+ tracked investments
1,663
Tracked investments
in this market
25
Firms ranked
highest scoring
Sort by
1

EIC Accelerator program

Series C+Belgium
Healthcare & Life SciencesIndustry & HardwareArtificial Intelligence & DataEnergy, Environment & MobilitySoftware & Developer ToolsConsumer, Lifestyle & Services
medical-devicehealthcareautomationmedtechsustainabilityartificial-intelligence

The EIC Accelerator program invests in innovative companies with a focus on artificial intelligence and data. They provide equity and debt financing to support the growth of companies primarily located in Europe.

90/ 110Grade A-

Investments

94

Exit Rate

2%

Alive

88

Portfolio Outcomes

88 Alive2 Acquired4 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
12 / 25
Deal Volume
30 / 30
Portfolio Outcomes
33 / 40
90 pts · Grade A-
2

Hiinova Capital

Series C+Belgium
Software & Developer ToolsFinance & BlockchainIndustry & HardwareCommerce & MarketingArtificial Intelligence & DataEnergy, Environment & Mobility
enterpriseautomationsaas-platformmarketingsupply-chainanalytics

Hi Inov is a European B2B venture capital firm that invests in early-stage companies. They focus on startups driving digital transformation and deep tech innovation, particularly in SaaS, AI, and IT management.

90/ 110Grade A-

Investments

57

Exit Rate

11%

Alive

36

Portfolio Outcomes

36 Alive6 Acquired15 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
7 / 25
Deal Volume
30 / 30
Portfolio Outcomes
38 / 40
90 pts · Grade A-
3

V-Bio Ventures

Series ABelgium
Healthcare & Life SciencesotherEnergy, Environment & MobilityArtificial Intelligence & Data
drug-developmentbiotechr-dhealthcaredrug developmentbiotechnology

Invests in early- to mid-stage life science companies with high growth potential. Focuses on transformational innovations in biotech, pharmaceutical, and agricultural sectors.

90/ 110Grade A-

Investments

25

Exit Rate

7%

Alive

18

Portfolio Outcomes

18 Alive2 Acquired1 Dead9 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
9 / 25
Deal Volume
30 / 30
Portfolio Outcomes
36 / 40
90 pts · Grade A-
4

Vesalius Biocapital

Series C+Belgium
Healthcare & Life SciencesSoftware & Developer ToolsIndustry & HardwareConsumer, Lifestyle & Services
digital-healthdrug-developmenthealthcarebiotechoncologyr-d

Vesalius Biocapital III invests in innovative biotech and life sciences companies primarily in Europe, focusing on transformative therapies and technologies with strong growth potential in healthcare.

87/ 110Grade A-

Investments

45

Exit Rate

27%

Alive

21

Portfolio Outcomes

21 Alive12 Acquired4 Dead8 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
5 / 25
Deal Volume
30 / 30
Portfolio Outcomes
37 / 40
87 pts · Grade A-
5

Verlinvest-CR JV

Series C+Belgium
otherSoftware & Developer ToolsCommerce & MarketingConsumer, Lifestyle & ServicesHealthcare & Life SciencesEnergy, Environment & Mobility
retaild2cplant-baseddessertbakerylate-night

Verlinvest-CR JV invests in innovative consumer brands and retail ventures in growth stages, focusing on companies that blend tradition with modern consumer trends to deliver sustainable value.

80/ 110Grade B

Investments

57

Exit Rate

2%

Alive

43

Portfolio Outcomes

43 Alive1 Acquired18 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
15 / 25
Deal Volume
30 / 30
Portfolio Outcomes
20 / 40
80 pts · Grade B
6
Industry & HardwareHealthcare & Life SciencesSoftware & Developer ToolsArtificial Intelligence & DataotherEnergy, Environment & Mobility
r-dalfa-pumpdsrfluid-overloadapplication-securitycloud-security

Capricorn Venture Partners invests in innovative companies in healthtech, cleantech, and software sectors across seed to series B stages, focusing on scalability and sustainability-driven growth.

79/ 110Grade B

Investments

19

Exit Rate

12%

Alive

12

Portfolio Outcomes

12 Alive2 Acquired3 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
20 / 40
79 pts · Grade B
7

Fund Plus

Series C+Belgium
Healthcare & Life SciencesIndustry & HardwareSoftware & Developer Toolsother
biotechdrug-developmentr-dhealthcareautoimmune-diseasescancer
79/ 110Grade B

Investments

17

Exit Rate

6%

Alive

11

Portfolio Outcomes

11 Alive1 IPO6 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
30 / 30
Portfolio Outcomes
20 / 40
79 pts · Grade B
8

Credibly Neutral

Series UnknownBelgium
Software & Developer ToolsFinance & BlockchainArtificial Intelligence & DataCommerce & MarketingHealthcare & Life Sciences
cryptoapidecentralized-socialdeveloper-platformfarcastercommunication

Invests in early-stage startups, demonstrated by participation in the $6m seed round of Belgian deeptech startup Belfort focused on novel chip technology for fully encrypted data processing.

73/ 110Grade C+

Investments

21

Exit Rate

4%

Alive

19

Portfolio Outcomes

19 Alive1 Acquired5 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
14 / 30
Portfolio Outcomes
30 / 40
73 pts · Grade C+
9

10x Group

Series CBelgium
Software & Developer ToolsFinance & BlockchainHealthcare & Life SciencesIndustry & HardwareCommerce & Marketing
cloudenterprisefinancial-servicesfintechsmb-servicessme-tech

Invests in early-stage and growth startups across Europe and Silicon Valley. Focuses on data, AI, and robotics sectors.

73/ 110Grade C+

Investments

10

Exit Rate

0%

Alive

7

Portfolio Outcomes

7 Alive2 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
8 / 25
Deal Volume
30 / 30
Portfolio Outcomes
20 / 40
73 pts · Grade C+
10

Hummingbird Ventures

Series BBelgium
Healthcare & Life SciencesSoftware & Developer ToolsConsumer, Lifestyle & ServicesFinance & BlockchainIndustry & HardwareCommerce & Marketing
fintechautomationbiotechr-dfinancial-serviceshealthcare

Hummingbird Ventures is a venture capital firm that invests in early-stage technology companies with global ambitions. They focus on disruptive technologies and scalable business models across various sectors.

72/ 110Grade C+

Investments

66

Exit Rate

4%

Alive

54

Portfolio Outcomes

54 Alive3 Acquired11 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
9 / 25
Deal Volume
30 / 30
Portfolio Outcomes
18 / 40
72 pts · Grade C+
11

Bioqube Ventures

Series ABelgium
Healthcare & Life SciencesIndustry & HardwareArtificial Intelligence & DataSoftware & Developer Tools
drug-discoveryr-dtherapeuticsbiotechdrug-developmentoncology
72/ 110Grade C+

Investments

6

Exit Rate

17%

Alive

4

Portfolio Outcomes

4 Alive1 Acquired1 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
10 / 30
Portfolio Outcomes
33 / 40
72 pts · Grade C+
12

PMV

Series BBelgium
Software & Developer ToolsHealthcare & Life SciencesIndustry & HardwareEnergy, Environment & MobilityFinance & BlockchainCommerce & Marketing
aianalyticsautomationdrug-discoveryenterprisedeveloper-tools

Focuses on companies in Belgium. Invests in the Commerce & Marketing and Healthcare & Life Sciences sectors, primarily in later stage companies.

71/ 110Grade C

Investments

28

Exit Rate

0%

Alive

17

Portfolio Outcomes

17 Alive2 Dead4 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
10 / 25
Deal Volume
30 / 30
Portfolio Outcomes
16 / 40
71 pts · Grade C
13
Energy, Environment & MobilitySoftware & Developer ToolsConsumer, Lifestyle & Servicesother
energy-managementrenewable-energyanalyticscleantechapplication-developmentev-charging

Focuses on growth and buyout capital for European energy transition scaleups and SMEs. They invest in companies that enable electrification and accelerate the energy transition, targeting grid enhancement, sustainable buildings, and industrial decarbonization.

71/ 110Grade C

Investments

14

Exit Rate

0%

Alive

11

Portfolio Outcomes

11 Alive2 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
16 / 25
Deal Volume
30 / 30
Portfolio Outcomes
10 / 40
71 pts · Grade C
14

Sofina

Series C+Belgium
69/ 110Grade C

Investments

55

Exit Rate

Alive

Portfolio Outcomes

Not enough tracked outcomes yet

Score Breakdown

Size Fit
15 / 15
Venture Signals
6 / 25
Deal Volume
30 / 30
Portfolio Outcomes
18 / 40
69 pts · Grade C
15

Astanor Ventures

Series C+Belgium
Industry & HardwareSoftware & Developer ToolsEnergy, Environment & MobilityArtificial Intelligence & DataConsumer, Lifestyle & ServicesHealthcare & Life Sciences
sustainabilityplant-basedfoodtechfood-deliveryagritechr-d

Astanor Ventures is a venture capital firm that invests in startups that are transforming the food and agriculture industry. They focus on companies that are developing sustainable and regenerative solutions to improve the food system, from farm to table.

68/ 110Grade C-

Investments

27

Exit Rate

4%

Alive

20

Portfolio Outcomes

20 Alive1 Acquired7 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
10 / 25
Deal Volume
30 / 30
Portfolio Outcomes
13 / 40
68 pts · Grade C-
16

InnoEnergy

Series C+Belgium
Energy, Environment & MobilitySoftware & Developer ToolsotherHealthcare & Life Sciences
energy-managementrenewable-energyelectric-vehiclescarbon-accountingdecarbonizationanalytics

InnoEnergy invests in innovation-driven startups focused on clean energy, sustainability, and digital transformation to scale solutions addressing major societal challenges in Europe.

67/ 110Grade C-

Investments

6

Exit Rate

0%

Alive

4

Portfolio Outcomes

4 Alive1 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
15 / 25
Deal Volume
30 / 30
Portfolio Outcomes
7 / 40
67 pts · Grade C-
17

GIMV

Series C+Belgium
Healthcare & Life SciencesotherSoftware & Developer ToolsConsumer, Lifestyle & ServicesIndustry & HardwareCommerce & Marketing
healthtechconstructiontechfoodtechinfrastructuree-commercehealthcare

GIMV invests in companies with a focus on healthcare and life sciences. They provide capital for growth and expansion, often participating in series B and later rounds.

65/ 110Grade C-

Investments

137

Exit Rate

14%

Alive

79

Portfolio Outcomes

79 Alive17 Acquired2 IPO39 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
9 / 25
Deal Volume
30 / 30
Portfolio Outcomes
11 / 40
65 pts · Grade C-
18
65/ 110Grade C-

Investments

7

Exit Rate

30%

Alive

5

Portfolio Outcomes

5 Alive3 Acquired2 Unknown

Score Breakdown

Size Fit
6 / 15
Venture Signals
10 / 25
Deal Volume
9 / 30
Portfolio Outcomes
40 / 40
65 pts · Grade C-
19

QBIC fund

Series ABelgium
Healthcare & Life SciencesSoftware & Developer ToolsIndustry & HardwareEnergy, Environment & MobilityArtificial Intelligence & Dataother
medical-devicebiotechr-dadvertisingbrowser-extensionsoftware-development
64/ 110Grade D+

Investments

51

Exit Rate

2%

Alive

31

Portfolio Outcomes

31 Alive1 Acquired24 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
26 / 30
Portfolio Outcomes
9 / 40
64 pts · Grade D+
20

Ackermans & van Haaren

Series BBelgium
64/ 110Grade D+

Investments

12

Exit Rate

0%

Alive

12

Portfolio Outcomes

12 Alive1 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
15 / 30
Portfolio Outcomes
20 / 40
64 pts · Grade D+
21

Mediahuis Ventures

Corporate VCSeries BBelgium
Software & Developer ToolsCommerce & MarketingConsumer, Lifestyle & Servicesother
employee-benefitslearning-platformadvertisingcontent-creationdigital-advertisingmarketing

Mediahuis Ventures is the corporate venture capital arm of Mediahuis, a leading European media group. They invest in innovative and fast-growing digital companies in sectors such as media tech, ad tech, marketplaces, and the future of work, seeking both financial returns and strategic value.

63/ 110Grade D+

Investments

11

Exit Rate

0%

Alive

8

Portfolio Outcomes

8 Alive3 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
16 / 25
Deal Volume
25 / 30
Portfolio Outcomes
7 / 40
63 pts · Grade D+
22

White Fund

Series ABelgium
Healthcare & Life SciencesSoftware & Developer Toolsother
digital-healthadoptioncommunitylocal-servicesnonprofitpet-care

Focuses on early-stage companies in Belgium. Primarily invests in the Healthcare & Life Sciences sector.

62/ 110Grade D+

Investments

14

Exit Rate

0%

Alive

9

Portfolio Outcomes

9 Alive7 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
13 / 30
Portfolio Outcomes
20 / 40
62 pts · Grade D+
23

Omega Fund

Series ABelgium
Healthcare & Life SciencesotherSoftware & Developer ToolsArtificial Intelligence & DataConsumer, Lifestyle & Services
clinical-stageoncologydrug-developmentbiotechr-dsmall-molecules
62/ 110Grade D+

Investments

10

Exit Rate

13%

Alive

13

Portfolio Outcomes

13 Alive2 IPO

Score Breakdown

Size Fit
15 / 15
Venture Signals
14 / 25
Deal Volume
20 / 30
Portfolio Outcomes
13 / 40
62 pts · Grade D+
24

Transition

Series ABelgium
Energy, Environment & MobilitySoftware & Developer ToolsFinance & BlockchainConsumer, Lifestyle & ServicesHealthcare & Life SciencesCommerce & Marketing
sustainabilityclean-energyroboticsclimate-techenergyenvironment
62/ 110Grade D+

Investments

7

Exit Rate

0%

Alive

7

Portfolio Outcomes

7 Alive1 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
15 / 25
Deal Volume
30 / 30
Portfolio Outcomes
2 / 40
62 pts · Grade D+
25

Innovation Industries

Series C+Belgium
Healthcare & Life SciencesIndustry & HardwareSoftware & Developer ToolsEnergy, Environment & MobilityArtificial Intelligence & Dataother
r-dhardwarehealthcaresustainabilitymedical-devicemedtech

Innovation Industries focuses on early-stage investments in Belgium and the Netherlands. They primarily target companies in the Industry & Hardware sector, often participating in Series A rounds.

61/ 110Grade D+

Investments

52

Exit Rate

0%

Alive

38

Portfolio Outcomes

38 Alive9 Unknown

Score Breakdown

Size Fit
15 / 15
Venture Signals
0 / 25
Deal Volume
30 / 30
Portfolio Outcomes
16 / 40
61 pts · Grade D+

Methodology

What the score measures, who is eligible, and what it deliberately excludes.

How is the Brouky score for Belgium calculated?
Each firm is scored out of 110 points across four measured components: portfolio outcomes (40), deal volume (30), risk adjustment (25) and cheque-size fit (15). The score is computed from tracked investments and portfolio company status. It is not editorial and firms cannot influence it.
Which firms are eligible for the Belgium ranking?
Venture and corporate venture funds headquartered in Belgium with at least 5 tracked investments. 50 firms qualify; the top 25 are listed. Angel investors, family offices, banks, accelerators and government vehicles are excluded because they are scored on a different basis and are not comparable.
How often is the ranking updated?
Scores are recomputed as new investments and portfolio outcomes are recorded, and this page refreshes daily.
My fund's data looks wrong. Can it be corrected?
Yes. Claim the fund's profile on Brouky to review the underlying investments and portfolio records, and the score updates from the corrected data.

Other rankings

GermanyUnited KingdomFranceNetherlandsSpainSwedenSwitzerlandDenmarkItalyNorwayFinlandCzech RepublicIrelandRomaniaPolandLuxembourgAustriaEstoniaPortugalUnited StatesIndiaIsraelSingaporeCanadaAustraliaChinaJapanUnited Arab Emirates